Antibodies leverage on their unique architecture to bind with an array of antigens. The strength of interaction has a direct relation to the affinity of the antibodies towards the antigen. In vivo affinity maturation is performed through multiple rounds of somatic hypermutation and selection in the germinal centre. This unique process involves intricate sequence rearrangements at the gene level via molecular mechanisms. The emergence of in vitro display technologies, mainly phage display and recombinant DNA technology, has helped revolutionize the way antibody improvements are being carried out in the laboratory. The adaptation of molecular approaches in vitro to replicate the in vivo processes has allowed for improvements in the way recomb...
In vitro selection technology has transformed the development of therapeutic monoclonal antibodies. ...
Phage display technology has emerged as the dominant approach in antibody engineering. Here I descri...
The discovery of hybridoma technology, described by Kohler and Milstein in 1975, and the resulting a...
Phage display technology has been widely used for antibody affinity maturation for de-cades. The lim...
The immune system is an important part of the physiology of higher organisms. In the immune system a...
During the last 15 years in vitro technologies opened powerful routes to combine the generation of l...
During the last 15 years in vitro technologies opened powerful routes to combine the generation of l...
<div><p>Phage display technology has been widely used for antibody affinity maturation for decades. ...
Since the initial description of phage display technology for the generation of human antibodies, a ...
Recombinant human antibody technology has been the cornerstone of the uprising of biologics in the p...
Antibodies are essential molecules for diagnosis and treatment of diseases caused by pathogens and t...
We report the construction and the use of a phage display human antibody library (>3 x 10(8) clones)...
The phage display is becoming a very powerful technology. Filamentous phages can present on their su...
Phage display bypasses the immune response by bringing the entire immune repertoire to a target anti...
Since its introduction almost 20 years ago, phage display technology has revolutionized approaches t...
In vitro selection technology has transformed the development of therapeutic monoclonal antibodies. ...
Phage display technology has emerged as the dominant approach in antibody engineering. Here I descri...
The discovery of hybridoma technology, described by Kohler and Milstein in 1975, and the resulting a...
Phage display technology has been widely used for antibody affinity maturation for de-cades. The lim...
The immune system is an important part of the physiology of higher organisms. In the immune system a...
During the last 15 years in vitro technologies opened powerful routes to combine the generation of l...
During the last 15 years in vitro technologies opened powerful routes to combine the generation of l...
<div><p>Phage display technology has been widely used for antibody affinity maturation for decades. ...
Since the initial description of phage display technology for the generation of human antibodies, a ...
Recombinant human antibody technology has been the cornerstone of the uprising of biologics in the p...
Antibodies are essential molecules for diagnosis and treatment of diseases caused by pathogens and t...
We report the construction and the use of a phage display human antibody library (>3 x 10(8) clones)...
The phage display is becoming a very powerful technology. Filamentous phages can present on their su...
Phage display bypasses the immune response by bringing the entire immune repertoire to a target anti...
Since its introduction almost 20 years ago, phage display technology has revolutionized approaches t...
In vitro selection technology has transformed the development of therapeutic monoclonal antibodies. ...
Phage display technology has emerged as the dominant approach in antibody engineering. Here I descri...
The discovery of hybridoma technology, described by Kohler and Milstein in 1975, and the resulting a...